Gene expression patterns in the lungs of patients with primary pulmonary hypertension: A gene microarray analysis

Circulation Research

Volumn 88, Issue 6, 2001, Pages 555-562

  Geraci, Mark W ^a,b   Moore, Mark ^a,b   Gesell, Tracy ^a,b   Yeager, Michael E ^a,b   Alger, Lori ^a,b   Golpon, Heiko ^a,b   Gao, Bifeng ^a,b   Loyd, James E ^a,b   Tuder, Rubin M ^a,b   Voelkel, Norbert F ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Division of Pulmonary Sciences and Critical Care Medicine   (United States)

Author keywords

Familial primary pulmonary hypertension; Lung tissue; Microarray gene profiling; Primary pulmonary hypertension

Indexed keywords

APOLIPOPROTEIN C3; BONE MORPHOGENETIC PROTEIN 2; LAMININ RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHOTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FAMILIAL DISEASE; FEMALE; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; MALE; MUSCLE HYPERTROPHY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR LESION; VASCULAR SMOOTH MUSCLE;

EID: 0035970577     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.6.555     Document Type: Article

References (46)

1. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension
2. Severe pulmonary hypertensive diseases: A perspective
3. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
4. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth
5. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension
6. New aspects in the reaction mechanism of phenol with peroxynitrite: The role of phenoxy radicals
7. HIV-related pulmonary hypertension: Analytic review of 131 cases
8. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
9. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
10. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension
11. Familial primary pulmonary hypertension (gene PPHI) is caused by mutations in the bone morphogenetic protein receptor-II gene
12. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension
13. Expression monitoring by hybridization to high-density oligonucleotide arrays
14. TGFβ signaling in growth control, cancer, and heritable disorders
15. Gene expression profile of aging and its retardation by caloric restriction
16. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
17. Disruption of the mouse necdin gene results in early pest-natal lethality
18. Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors
19. Identification of Tek/Tie2 binding partners: Binding to a multifunctional docking site mediates cell survival and migration
20. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
21. Octamer-dependent in vivo expression of the endothelial cell-specific TIE2 gene
22. Elongation factor-1α is a novel substrate of rho-associated kinase
23. Cloning of 67-kDa laminin receptor cDNA and gene expression in normal and malignant cell lines of the human lung
24. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
25. Detection of multiple bone morphogenetic protein messenger ribonucleic acids and their signal transducer, smad1, during mouse decidualization
26. Hox genes in human lung: Altered expression in primary pulmonary hypertension and emphysema
27. Synexpression groups in eukaryotes
28. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis
29. Targeting of substrates to the 26S proteasome
30. Structure and functions of the 20S and 26S proteasomes
31. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
32. Endothelial cell death and decreased expression of vascular endothelial growth factor and its receptor KDR/Flk-1 in smoking-induced emphysema
33. Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death
34. Primary pulmonary hypertension between inflammation and cancer
35. Ku80: Product of the XRCC5 gene and its role in DNA repair and V(D)J recombination
36. Increased mRNA expression of a laminin-binding protein in human colon carcinoma: Complete sequence of a full-length cDNA encoding the protein
37. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32
38. Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia
39. Smooth muscle α-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex
40. Smooth muscle differentiation marker gene expression is regulated by rhoA-mediated actin polymerization
41. Calmodulin differentially modulates smad1 and smad2 signaling
42. Signaling of transforming growth factor-β family members through smad proteins
43. Characterization of the mouse smad1 gene and its expression pattern in adult mouse tissues
44. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
45. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension